An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR)

Peer Review reports

Original Submission
26 Apr 2021	Submitted	Original manuscript
19 Sep 2021	Reviewed	Reviewer Report - Muslim Syed
26 Sep 2021	Reviewed	Reviewer Report - Hesamaddin Shirzad-Aski
13 Oct 2021	Author responded	Author comments - Stephen Ian Walimbwa
Resubmission - Version 2
13 Oct 2021	Submitted	Manuscript version 2
15 Oct 2021	Reviewed	Reviewer Report - Muslim Syed
18 Oct 2021	Reviewed	Reviewer Report - Hesamaddin Shirzad-Aski
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
25 Oct 2021	Editorially accepted
23 Nov 2021	Article published	10.1186/s13063-021-05752-1

Back to article page